NASDAQ · Biotechnology

Exscientia plc (EXAI) Stock

$4.84 NASDAQ: EXAI Healthcare

Exscientia plc is a pioneering pharmatech firm that leverages artificial intelligence (AI) to revolutionize drug discovery and development. The company provides a comprehensive, AI-driven platform that spans the entire drug development lifecycle.

Valuation

MetricValue
Price$4.84
Market Cap$633.18M
P/E Ratio-3.06
P/B Ratio1.25
P/S Ratio23.56
EPS (TTM)$-1.18
52-Week High$4.84
52-Week Low$4.84
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.96%
ROA-28.58%
ROCE-39.49%
Gross Margin-36.48%
Operating Margin-876.56%
Net Margin-726.94%
Debt/Equity0.05
Current Ratio6.22

Annual Financials (USD)

Metric20192020202120222023
Revenue$9.0M$10.0M$27.0M$27.0M$20.0M
Operating Profit$-8.0M$-23.0M$-55.0M$-145.0M$-176.0M
Net Profit$-6.0M$-22.0M$-49.0M$-119.0M$-146.0M
EPS$-0.05$-0.17$-0.42$-0.97$-1.18
Op Margin-89.8%-239.8%-200.7%-533.7%-876.6%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$54.0M$106.0M$475.0M$530.0M$511.0M
Total Liabilities$25.0M$26.0M$55.0M$139.0M$155.0M
Cash$41.0M$82.0M$417.0M$329.0M$258.0M
Borrowings$1.0M$3.0M$5.0M$11.0M$19.0M

Latest News

Lockheed Martin paying $3.5 billion for naval defense-tech company Axios · Jul 6, 2026 France’s Thales to Take Stake in Maritime Drone Maker Exail Ahead of Takeover The Wall Street Journal · Jul 6, 2026 European Indexes Edge Higher at Open The Wall Street Journal · Jul 6, 2026 Global Market's Hidden Value: 3 Stocks Estimated Below Intrinsic Worth Simply Wall St. · Jun 3, 2026 European Value Stocks Trading Below Estimated Worth In May 2026 Simply Wall St. · May 5, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$9.0M$-29.0M$-5.0M$-60.0M$-118.0M
Investing Cash Flow$-4.0M$-8.0M$-34.0M$-143.0M$-50.0M
Financing Cash Flow$0$0$0$-2.0M$0
Net Cash Flow$7.0M$42.0M$500.0M$-155.0M$-145.0M
Free Cash Flow$7.0M$-32.0M$-12.0M$-82.0M$-144.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.44
EV / EBITDA-1.61
FCF Yield-30.49%
Quick Ratio6.22
Interest Coverage-164.95
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACCDAccolade, Inc. $7.02 +0.00% -5.28 $575.59M 0.00%
ASLNASLAN Pharmaceuticals Limited $0.60 -14.27% -0.06 $777.12M 0.00%
CDMOAvid Bioservices, Inc. $12.49 +0.00% -5.60 $798.90M 0.00%
ICVXIcosavax, Inc. $15.31 -0.91% -6.87 $769.04M 0.00%
IKNAIkena Oncology, Inc. $17.16 +1152.55% -22.36 $718.82M 0.00%

About Exscientia plc

Exscientia plc is a pioneering pharmatech firm that leverages artificial intelligence (AI) to revolutionize drug discovery and development. The company provides a comprehensive, AI-driven platform that spans the entire drug development lifecycle. This integrated system supports crucial stages, including identifying disease targets, designing potential drug candidates, developing translational models, and optimizing patient selection for clinical trials. A key area of focus for Exscientia is the development of small molecule drug candidates. Through its advanced AI capabilities, the platform not only facilitates the efficient design of novel drug molecules but also employs AI-guided assessments to ensure patients receive the most suitable therapeutic interventions. Established in 2012, Exscientia plc is headquartered in Oxford, United Kingdom.

Exscientia plc is headquartered in GB.

Exscientia plc (EXAI) stock trades at $4.84 with a market capitalization of $633.18M. The stock is valued at a price-to-earnings (P/E) ratio of -3.06, price-to-book of 1.25, price-to-sales of 23.56. Over the past 52 weeks the stock has ranged between $4.84 and $4.84, and currently trades at its 52-week high.

On profitability, Exscientia plc generates a return on equity (ROE) of -38.96%, return on capital employed of -39.49%, an operating margin of -876.56%, a net profit margin of -726.94%.

Official website: www.exscientia.ai

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides